| 000 -LEADER | |
|---|---|
| fixed length control field | 01161nam a22001457a 4500 |
| 100 ## - MAIN ENTRY--AUTHOR NAME | |
| Personal name | Inter-Governmental Action Group against Money Laundering in West Africa (GIABA) |
| 245 ## - TITLE STATEMENT | |
| Title | Money Laundering Resulting from the Counterfeiting of Pharmaceuticals in West Africa |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication | Senegal |
| Name of publisher | Inter-Governmental Action Group against Money Laundering in West Africa (GIABA) |
| Year of publication | 2017 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Number of Pages | 56p. |
| 490 ## - SERIES STATEMENT | |
| Series statement | Typologies Report |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | This study, published by Inter-Governmental Action Group against Money Laundering in West Africa (GIABA) is aimed at understanding the nature and magnitude of money laundering in West Africa as a result of counterfeiting pharmaceuticals. The study encourages countries to reorganise approaches in tracking, tracing and encoding legitimate products. Based on the findings of the study, one of the recommendations made is that law enforcement and regulatory officials involved in counterfeit pharmaceuticals should be adequately trained. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical Term | Money Laundering, Illicit Wealth, Corruption |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | iffoadatabase.trustafrica.org/iff/GIABA_Typologies_Report_ML_and_Counterfeit_Pharmaceutical.pdf |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Computer Files |
No items available.